July 2018
Volume 59, Issue 9
Open Access
ARVO Annual Meeting Abstract  |   July 2018
Optical Pathway Imaging and Straylight Evaluation of Opacified Intraocular Lenses
Author Affiliations & Notes
  • Hyeck Soo Son
    David J. Apple Center for Vision Research, Heidelberg, Germany
    University Eye Hospital Heidelberg, Heidelberg, Germany
  • Timur Mert Yildirim
    David J. Apple Center for Vision Research, Heidelberg, Germany
    University Eye Hospital Heidelberg, Heidelberg, Germany
  • Grzegorz Łabuz
    David J. Apple Center for Vision Research, Heidelberg, Germany
  • Gerd Auffarth
    David J. Apple Center for Vision Research, Heidelberg, Germany
    University Eye Hospital Heidelberg, Heidelberg, Germany
  • Footnotes
    Commercial Relationships   Hyeck Soo Son, None; Timur Yildirim, None; Grzegorz Łabuz, None; Gerd Auffarth, None
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science July 2018, Vol.59, 266. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Hyeck Soo Son, Timur Mert Yildirim, Grzegorz Łabuz, Gerd Auffarth; Optical Pathway Imaging and Straylight Evaluation of Opacified Intraocular Lenses. Invest. Ophthalmol. Vis. Sci. 2018;59(9):266.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Intraocular lens (IOL) calcification is a serious condition that may degrade patients’ vision. Despite its relatively low incidence rate, it may result in significant patient complaints and IOL exchange. One of the complaints that patients with opacified lenses may report is increased sensitivity to (glaring) light sources, which may originate from light scattering by lens opacities. Therefore, in this laboratory study, we aimed to assess the scattering effects of five opacified lenses by qualitatively visualizing the ray propagation and quantitatively measuring the level of light scatter.

Methods : Four opacified-IOL explants were studied Euromaxx ALI313Y (Argonoptics), Acri.Lyc 44S (Acri.Tec), LS-312 MF 30 (Oculentis), and Adatomed 88 TI (Adatomed) as well as one lens with laboratory-induced glistenings (PC-60AD [Hoya]) and a clear control IOL. To identify the type of opacification, gross examination of the explanted lenses was performed using light microscopy. Each IOL was placed in an eye model on an optical bench set-up and illuminated by green laser light. Images of the optical pathway, which were made visible by fluorescein solution, were taken with a digital camera. Straylight levels were measured using the C-Quant device (Oculus) adapted for in vitro evaluation of IOLs. Measurements were performed at a 7 degree scatter angle. Results were compared to those of the control lens.

Results : The light-visualization set-up showed more light scatter in the opacified lenses than in the control, which was visible as increased light intensity outside the main lens focus. Each opacified lens demonstrated its own characteristic ray propagation behavior. The average straylight parameter (s) was 76.6±107.8 deg^2/sr. The highest straylight was observed in Euromaxx (s=289.71 deg^2/sr), which exhibited extensive granular deposits throughout its optic. In Adatomed and Acri.Ly lenses opacification was limited to the lens center with a straylight level of 18.7 deg^2/sr and 48.1 deg^2/sr, respectively. The IOL with glistenings showed s=22.6 deg^2/sr, and for the control lens it was s=1.7 deg^2/sr.

Conclusions : We found that straylight was increased in all opacified lenses as compared to that of the control. A veil of light that results from increased light scattering could be qualitatively assessed by the optical pathway visualization. The studied IOL opacifications appear to be significant sources of glare.

This is an abstract that was submitted for the 2018 ARVO Annual Meeting, held in Honolulu, Hawaii, April 29 - May 3, 2018.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×